Vistagen Therapeutics, Inc.
Key Metrics
Market Snapshot
About
Vistagen Therapeutics, Inc. is a clinical-stage biopharmaceutical company pioneering new treatments for psychiatric and neurological disorders based on nose-to-brain neurocircuitry. The company is developing a portfolio of investigational pherine drug candidates designed to activate chemosensory neurons in the nasal passages and modulate specific neural circuits without systemic exposure. Vistagen focuses on conditions including social anxiety disorder, major depressive disorder, and other CNS conditions.